Doctors optimistic about Pfizer COVID-19 pill

[KSTP-TV News, December 14, 2021] Doctors who treat COVID-19 patients in the Twin Cities, including Allina Health's infectious disease specialist, Dr. Frank Rhame, are voicing optimism over Pfizer's antiviral pill, known as Paxlovid. Pfizer released new data from its clinical trials of Paxlovid Tuesday, showing the pill significantly reduced the risk of hospitalization and death.

The drug company said nearly 2,250 adults at high risk of the virus were enrolled in the trials. They found the medication was 89% effective at preventing both hospitalization and death for those who took the pills within three days of showing symptoms and 88% effective for those who started the pills within five days.

Posted on December 14, 2021 in coronavirus

Share this article